Mark Anderson has been elected to the National Academy of Medicine, which was established in 1970 to acknowledge highly regarded professionals in the diverse areas of medicine.
Election to this exclusive group is recognition of the outstanding work Mark and his team have been performing for many years in defining how the thymus regulates the immune system and how dysfunction in the organ can cause autoimmune diseases, including type 1 diabetes. Mark joins Jeffrey Bluestone as the second member of our faculty upon which this great honor has been bestowed.
“This distinguished and diverse class of new members is a truly exceptional group of scholars and leaders whose expertise in science, medicine, health, and policy will be integral to helping the NAM address today’s most pressing health challenges and inform the future of health and health care for the benefit of everyone around the globe,” said National Academy of Medicine President Victor J. Dzau in a press release. “It is my privilege to welcome these esteemed individuals to the National Academy of Medicine.”
Along with Mark, this year's distinguished group includes Edward Chang, Alexsandar Rajkovic, and Robert Wachter. "I am so glad that Mark’s hard work on uncovering mechanisms behind autoimmune diseases and T1D is being recognized with this great honor," said Matthias Hebrok, Director of Diabetes Center.